Pay in 4 interest-free payments of $31.25 Learn more
Ships within 48 hours ยท Estimated delivery Aug 29 - Sep 3
๐งช Test Report is available via: Janoshik Test Report
Retatrutide is a triple agonist targeting the GLP-1
designed to support effortless weight control and improve glucose balance
and cellular regeneration pathways
and cellular resilience
Retaklik (Retatrutide) Dosage:60mg ๐งช Test Report is availableRetaklik (Retatrutide) is a triple agonist targeting the GLP 1, GIP, and glucagon receptors, designed to support effortless weight control and improve glucose balance. By activating these key metabolic pathways, it recalibrates appetite, enhances energy output, and boosts overall metabolic efficiency for a smoother, more empowered transformation experience. Janoshik Test Report: 20mg, 40mg, 60mg
US$ 19.99
US$ 147.50
US$ 160.00
US$ 49.99
US$ 159.99
US$ 28.49
US$ 59.99
US$ 247.50
US$ 19.95
US$ 124.97
US$ 694.50
US$ 18.99
